NASDAQ:IBBQ Invesco Nasdaq Biotechnology ETF (IBBQ) Price, Holdings, & News $21.92 -0.33 (-1.48%) Closing price 07/18/2025 03:59 PM EasternExtended Trading$21.82 -0.10 (-0.46%) As of 07/18/2025 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock About Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IBBQ alerts:Sign Up Key Stats Today's Range$21.91▼$22.2650-Day Range$19.52▼$22.3852-Week Range$17.84▼$24.84Volume7,137 shsAverage Volume17,168 shsMarket Capitalization$38.36 millionAssets Under Management$33.39 millionDividend Yield1.00%Net Expense Ratio0.19%Aggregate RatingModerate Buy ETF Overview The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco. Read More Invesco Nasdaq Biotechnology ETF ExpensesTypeIBBQHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.19%0.56%0.56%0.54%0.53%Other Expenses0.00%0.47%0.56%0.52%0.56%Total Expense0.19%0.75%0.76%0.73%0.73%Fee Waiver0.00%-0.67%-0.66%-0.50%-0.63%Net Expense0.19%0.60%0.63%0.63%0.60% Receive IBBQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco Nasdaq Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address IBBQ ETF News HeadlinesInvesco Is S&P 500’s Best Stock Friday. It Hopes to Start Making Money From QQQ.July 18 at 2:22 PM | msn.comInvesco Aims to Unlock Hundreds of Millions in Profit From QQQJuly 17 at 11:36 PM | msn.comElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. | Brownstone Research (Ad)Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Shares Up 1.1% - Still a Buy?July 15, 2025 | americanbankingnews.comInvesco Nasdaq Biotechnology ETF declares quarterly distribution of $0.02870June 23, 2025 | msn.comU.S. Nuclear Push and AI Demand Ignite Uranium ETF RallyMay 27, 2025 | theglobeandmail.comSee More Headlines IBBQ ETF - Frequently Asked Questions How have IBBQ shares performed this year? Invesco Nasdaq Biotechnology ETF's stock was trading at $21.52 at the start of the year. Since then, IBBQ stock has increased by 1.9% and is now trading at $21.92. How do I buy shares of Invesco Nasdaq Biotechnology ETF? Shares of IBBQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Invesco Nasdaq Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Invesco Nasdaq Biotechnology ETF investors own include Vanguard Total Stock Market ETF (VTI), Verizon Communications (VZ), CrowdStrike (CRWD), Docusign (DOCU), Meta Platforms (META), NVIDIA (NVDA) and Shopify (SHOP). Fund Details IssuerInvesco Fund NameInvesco Nasdaq Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBBQ Inception Date6/11/2021 Fund ManagerPeter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser Previous SymbolNASDAQ:IBBQ WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNasdaq Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings260 Fund Statistics Assets Under Management$33.39 million Average Daily Volume$0.00 Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerLatour Trading Options OptionableOptionable Options Volume1 Put Options1 Call Options1 Short Interest5,600 shs Miscellaneous Outstanding Shares1,750,000Beta0.61 Creation Unit10,000 Creation Fee$600.00 Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report Top 10 IBBQ HoldingsVertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 7.83%Gilead Sciences (NASDAQ:GILD)Holding Weight: 7.77%Amgen (NASDAQ:AMGN)Holding Weight: 7.72%Regeneron Pharmaceuticals (NASDAQ:REGN)Holding Weight: 6.23%AstraZeneca (NASDAQ:AZN)Holding Weight: 4.67%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 4.04%Biogen (NASDAQ:BIIB)Holding Weight: 2.10%Insmed (NASDAQ:INSM)Holding Weight: 1.96%argenex (NASDAQ:ARGX)Holding Weight: 1.89%Summit Therapeutics (NASDAQ:SMMT)Holding Weight: 1.74%Full Holdings DetailsIBBQ Sector ExposureIBBQ Industry Exposure This page (NASDAQ:IBBQ) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
